Incubator chamber

Fast and precise

User friendly

Max Cell Vitality

Laser & Plasma

hybrid printing

Why are you Interested in MOC bioprinters?



MOC Biotechnologies Inc. is the innovative business of 2023, providing novel solutions for the life sciences and preclinical CRO. MOC Biotechnologies Inc. offers cutting-edge biomechatronic systems for biotechnology, life sciences, and biology research. We are proud to deliver world-class solutions for research centers, universities, laboratories, and institutes. MOC Biotech uses 4D hybrid bioprinting to accelerate drug discovery across research areas, including cancer research. With our novel smart bed technology, they deliver results faster, more cost-effectively, and with greater accuracy. Pre-clinical research for drug discoveries or personalized medicine requires standardized systems with validated biological models and it will be feasible with our novel 4D hybrid bioprinting technology. MOC biotechnologies present novel hybrid 4D-bioprinting systems with unique Bioink composite structures that change shape upon physical stimulation. The artificial creation of human tissue and internal organs, animal models, and artificial plants and meats may sound like a futuristic dream but, incredibly, much of it is happening right now, so let’s save our planet by starting bioprinting with MOC.

hybrid bioprinting

MOC biotechnologies incorporation offers a hybrid bioprinter to revolutionize bio-sciences. It brings the next generation of products that change the future of bioprinting for novel human organs and tissues, mimicking nature and manufacturing leaves, seeds, plants, or microorganisms’ research. The world’s first scaffold treatment with laser and plasma is added in MOC so the stem cell adhesion and fermentation were increased significantly. MOC novel technologies will combine various additive manufacturing elements and 3D cell printing technologies to develop, promote, mass-produce, bioprinting, and microculture environment control technology.

Clone,Future of Life

The world’s first hybrid bioprinting technology is able to clone the detail required to simultaneously recapitulate hard and soft tissue for human organs. We Developed Magical Organ Cloner (MOC) system with several state of art technology to print several materials such as hydrogels, polymers, liquid composite, drugs, and special cell mediums with a unique intelligent injection system. MOC is an IoT system that can control the printing parameter automatically and its unique chamber has incubation parameters so the printing time could be added and the patient’s stem cells vitality is assured.

MOC Biotechnologies Inc. present novel solutions for life sciences Preclinical CRO

MOC biotechnologies Inc. offers cutting-edge biomechatronic systems for biotechnology, life sciences, and biology research. We are proud to deliver world-class solutions for research centers, Universities, laboratories, and institutes. MOC Biotech uses 4D hybrid bioprinting to accelerate drug discovery across research areas, such as cancer research. With our novel smart bed technology we deliver results faster, cheaper, and with more accuracy

The Further Global Leader in

bioprinting field